Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01-15

AUTHORS

Douglas Mapel, Michael Schum, Marianne Yood, Jeffrey Brown, David Miller, Kourtney Davis

ABSTRACT

AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96–1.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69–1.22) or SFC (OR=1.03; 95%CI: 0.74–1.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia. More... »

PAGES

109-117

Identifiers

URI

http://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072

DOI

http://dx.doi.org/10.4104/pcrj.2009.00072

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041801277

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20082059


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Inhalation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenal Cortex Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androstadienes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchodilator Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delayed-Action Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluticasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Longitudinal Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pneumonia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Disease, Chronic Obstructive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salmeterol Xinafoate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA", 
          "id": "http://www.grid.ac/institutes/grid.419338.4", 
          "name": [
            "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mapel", 
        "givenName": "Douglas", 
        "id": "sg:person.01204002445.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204002445.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA", 
          "id": "http://www.grid.ac/institutes/grid.419338.4", 
          "name": [
            "Lovelace Clinic Foundation, Albuquerque, New Mexico, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schum", 
        "givenName": "Michael", 
        "id": "sg:person.0632005344.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005344.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yood", 
        "givenName": "Marianne", 
        "id": "sg:person.0754044324.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754044324.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Jeffrey", 
        "id": "sg:person.016162107014.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016162107014.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline, Research Triangle Park, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline, Research Triangle Park, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miller", 
        "givenName": "David", 
        "id": "sg:person.01133555375.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133555375.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GlaxoSmithKline, Research Triangle Park, North Carolina, USA", 
          "id": "http://www.grid.ac/institutes/grid.418019.5", 
          "name": [
            "GlaxoSmithKline, Research Triangle Park, North Carolina, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "Kourtney", 
        "id": "sg:person.0724211141.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724211141.21"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-01-15", 
    "datePublishedReg": "2010-01-15", 
    "description": "AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96\u20131.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69\u20131.22) or SFC (OR=1.03; 95%CI: 0.74\u20131.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia.", 
    "genre": "article", 
    "id": "sg:pub.10.4104/pcrj.2009.00072", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1371256", 
        "issn": [
          "1471-4418", 
          "2055-1010"
        ], 
        "name": "npj Primary Care Respiratory Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "risk of pneumonia", 
      "combination inhaler", 
      "COPD patients", 
      "odds ratio", 
      "non-significant increased risk", 
      "cases of pneumonia", 
      "adjusted odds ratio", 
      "MethodThe study population", 
      "case-control method", 
      "increased risk", 
      "lung disease", 
      "clinical history", 
      "advanced age", 
      "study population", 
      "pneumonia", 
      "only treatment", 
      "patients", 
      "corticosteroids", 
      "bronchodilators", 
      "care organizations", 
      "risk", 
      "inhaler", 
      "administrative data", 
      "SABD", 
      "treatment", 
      "COPD", 
      "ConclusionTreatment", 
      "AimTo", 
      "therapy", 
      "LABA", 
      "disease", 
      "severity", 
      "age", 
      "population", 
      "individuals", 
      "database", 
      "history", 
      "cases", 
      "different parts", 
      "IC", 
      "combination", 
      "data", 
      "ratio", 
      "USA", 
      "part", 
      "method", 
      "organization", 
      "users"
    ], 
    "name": "Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators", 
    "pagination": "109-117", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041801277"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.4104/pcrj.2009.00072"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20082059"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.4104/pcrj.2009.00072", 
      "https://app.dimensions.ai/details/publication/pub.1041801277"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.4104/pcrj.2009.00072"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.4104/pcrj.2009.00072'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      20 PREDICATES      96 URIs      88 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.4104/pcrj.2009.00072 schema:about N027110c7ae084cea949876d634af3400
2 N031ac4f1b75f4e209df174ea3dd9efee
3 N0d75bf7c5b4545d9bbf50b00bdf7f541
4 N244697fdc450450d93946c4b832fa3d9
5 N258106c8f724443dbc62b5950c8ada72
6 N27aef196cf084ef39ec1c4a99c2c0cfa
7 N4dff804d3df24108857bdc2c5459016c
8 N69a98f5dfdbb43109468d1191573bd00
9 N6d8a27b1eaf347cba6e5fdb35d67c780
10 N6f3ec03e85854239838f8bc2700de7e4
11 N70a7977b76e048389628247ee50f9c1e
12 N7c198dbdae6f4ad49f7cd9c97ce54795
13 N823196c990574e3d96585989fedb56e2
14 N90e48cd2ce8b4698aea675ffb029485f
15 N9803a4a67f9f4c0c82ddc6ead797e91e
16 N9a9f6dab880a45f982f49c1de12088c8
17 N9f297447740d46d7809044028ea6230b
18 Na50e100b784b48f3a2fef4ef6dc69de3
19 Na6dc27f9129a4f2cad0a77568bd7e004
20 Nc171805c02dc4549a61975708627e2a0
21 Nc980fc2eb85143a89d68bd1f907a58f3
22 Nec7106b79e8b430f8fa783dde3a152ab
23 Nf43184a5afa845f69bc87bc293e722e4
24 anzsrc-for:11
25 anzsrc-for:1102
26 schema:author N602964f9dfc54fb88006096a5d43396a
27 schema:datePublished 2010-01-15
28 schema:datePublishedReg 2010-01-15
29 schema:description AimTo assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in combination, compared to those using only short-acting bronchodilators (SABD).MethodThe study population comprised 5245 individuals using inhaled treatment for COPD, identified from the databases of three large regional managed care organisations from different parts of the USA. Longitudinally-collected administrative data were obtained on their clinical histories and treatments. Nested case-control methods were used to calculate adjusted odds ratios (OR) for the risk of pneumonia while on therapy.Results2154 patients had at least one diagnosed case of pneumonia between 1st September 2001 and 31st August 2003. Relative to SABD, the only treatment associated with a non-significant increased risk of pneumonia was ICS used alone (OR=1.29; 95%CI: 0.96–1.73; p=0.09). Users of LABA alone (OR=0.92; 95%CI: 0.69–1.22) or SFC (OR=1.03; 95%CI: 0.74–1.42) had no increased risk for pneumonia relative to SABD. Advanced age and severity of lung disease were strongly associated with increased risk for pneumonia.ConclusionTreatment with ICS or an ICS/LABA combination inhaler was not associated with a significantly increased risk of developing pneumonia.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N54f6f42b856b4274a6a998b675ed9cea
33 Nebe66a88141a4646b576b52692a2e053
34 sg:journal.1371256
35 schema:keywords AimTo
36 COPD
37 COPD patients
38 ConclusionTreatment
39 IC
40 LABA
41 MethodThe study population
42 SABD
43 USA
44 adjusted odds ratio
45 administrative data
46 advanced age
47 age
48 bronchodilators
49 care organizations
50 case-control method
51 cases
52 cases of pneumonia
53 clinical history
54 combination
55 combination inhaler
56 corticosteroids
57 data
58 database
59 different parts
60 disease
61 history
62 increased risk
63 individuals
64 inhaler
65 lung disease
66 method
67 non-significant increased risk
68 odds ratio
69 only treatment
70 organization
71 part
72 patients
73 pneumonia
74 population
75 ratio
76 risk
77 risk of pneumonia
78 severity
79 study population
80 therapy
81 treatment
82 users
83 schema:name Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators
84 schema:pagination 109-117
85 schema:productId N65ee6fc89eed47509477efa0ec9c81b5
86 N7ca9f29692394c1f94b2d0d4bd910677
87 Ne33812386d954abeb796bfe77caf89d7
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041801277
89 https://doi.org/10.4104/pcrj.2009.00072
90 schema:sdDatePublished 2022-08-04T16:58
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N155cfbc716ce4635ba3044b9e2368758
93 schema:url https://doi.org/10.4104/pcrj.2009.00072
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N027110c7ae084cea949876d634af3400 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Adrenal Cortex Hormones
99 rdf:type schema:DefinedTerm
100 N031ac4f1b75f4e209df174ea3dd9efee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Adult
102 rdf:type schema:DefinedTerm
103 N0d75bf7c5b4545d9bbf50b00bdf7f541 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Female
105 rdf:type schema:DefinedTerm
106 N155cfbc716ce4635ba3044b9e2368758 schema:name Springer Nature - SN SciGraph project
107 rdf:type schema:Organization
108 N244697fdc450450d93946c4b832fa3d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Androstadienes
110 rdf:type schema:DefinedTerm
111 N258106c8f724443dbc62b5950c8ada72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Bronchodilator Agents
113 rdf:type schema:DefinedTerm
114 N27aef196cf084ef39ec1c4a99c2c0cfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Risk Factors
116 rdf:type schema:DefinedTerm
117 N27d631c612824814aad584d25484e05b rdf:first sg:person.0632005344.67
118 rdf:rest N3a36952d64894ae1a13813b79488a801
119 N3a36952d64894ae1a13813b79488a801 rdf:first sg:person.0754044324.05
120 rdf:rest N8d89d4bcac5e4ac8a9c6fa5ca2996453
121 N4dff804d3df24108857bdc2c5459016c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Delayed-Action Preparations
123 rdf:type schema:DefinedTerm
124 N54f6f42b856b4274a6a998b675ed9cea schema:volumeNumber 19
125 rdf:type schema:PublicationVolume
126 N602964f9dfc54fb88006096a5d43396a rdf:first sg:person.01204002445.88
127 rdf:rest N27d631c612824814aad584d25484e05b
128 N65ee6fc89eed47509477efa0ec9c81b5 schema:name doi
129 schema:value 10.4104/pcrj.2009.00072
130 rdf:type schema:PropertyValue
131 N69a98f5dfdbb43109468d1191573bd00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Case-Control Studies
133 rdf:type schema:DefinedTerm
134 N6d8a27b1eaf347cba6e5fdb35d67c780 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Longitudinal Studies
136 rdf:type schema:DefinedTerm
137 N6f3ec03e85854239838f8bc2700de7e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Pulmonary Disease, Chronic Obstructive
139 rdf:type schema:DefinedTerm
140 N6f922f71fdcc4ff9871b6b9ed00e545a rdf:first sg:person.0724211141.21
141 rdf:rest rdf:nil
142 N70a7977b76e048389628247ee50f9c1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Severity of Illness Index
144 rdf:type schema:DefinedTerm
145 N7c198dbdae6f4ad49f7cd9c97ce54795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Albuterol
147 rdf:type schema:DefinedTerm
148 N7ca9f29692394c1f94b2d0d4bd910677 schema:name pubmed_id
149 schema:value 20082059
150 rdf:type schema:PropertyValue
151 N823196c990574e3d96585989fedb56e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Odds Ratio
153 rdf:type schema:DefinedTerm
154 N8d89d4bcac5e4ac8a9c6fa5ca2996453 rdf:first sg:person.016162107014.93
155 rdf:rest Nda7cf0de17c04449b2b57785f5a9e761
156 N90e48cd2ce8b4698aea675ffb029485f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Pneumonia
158 rdf:type schema:DefinedTerm
159 N9803a4a67f9f4c0c82ddc6ead797e91e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 N9a9f6dab880a45f982f49c1de12088c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Middle Aged
164 rdf:type schema:DefinedTerm
165 N9f297447740d46d7809044028ea6230b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Age Factors
167 rdf:type schema:DefinedTerm
168 Na50e100b784b48f3a2fef4ef6dc69de3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Aged
170 rdf:type schema:DefinedTerm
171 Na6dc27f9129a4f2cad0a77568bd7e004 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Administration, Inhalation
173 rdf:type schema:DefinedTerm
174 Nc171805c02dc4549a61975708627e2a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Drug Therapy, Combination
176 rdf:type schema:DefinedTerm
177 Nc980fc2eb85143a89d68bd1f907a58f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Salmeterol Xinafoate
179 rdf:type schema:DefinedTerm
180 Nda7cf0de17c04449b2b57785f5a9e761 rdf:first sg:person.01133555375.45
181 rdf:rest N6f922f71fdcc4ff9871b6b9ed00e545a
182 Ne33812386d954abeb796bfe77caf89d7 schema:name dimensions_id
183 schema:value pub.1041801277
184 rdf:type schema:PropertyValue
185 Nebe66a88141a4646b576b52692a2e053 schema:issueNumber 2
186 rdf:type schema:PublicationIssue
187 Nec7106b79e8b430f8fa783dde3a152ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Fluticasone
189 rdf:type schema:DefinedTerm
190 Nf43184a5afa845f69bc87bc293e722e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Male
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
197 schema:name Cardiorespiratory Medicine and Haematology
198 rdf:type schema:DefinedTerm
199 sg:journal.1371256 schema:issn 1471-4418
200 2055-1010
201 schema:name npj Primary Care Respiratory Medicine
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01133555375.45 schema:affiliation grid-institutes:grid.418019.5
205 schema:familyName Miller
206 schema:givenName David
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133555375.45
208 rdf:type schema:Person
209 sg:person.01204002445.88 schema:affiliation grid-institutes:grid.419338.4
210 schema:familyName Mapel
211 schema:givenName Douglas
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204002445.88
213 rdf:type schema:Person
214 sg:person.016162107014.93 schema:affiliation grid-institutes:grid.38142.3c
215 schema:familyName Brown
216 schema:givenName Jeffrey
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016162107014.93
218 rdf:type schema:Person
219 sg:person.0632005344.67 schema:affiliation grid-institutes:grid.419338.4
220 schema:familyName Schum
221 schema:givenName Michael
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005344.67
223 rdf:type schema:Person
224 sg:person.0724211141.21 schema:affiliation grid-institutes:grid.418019.5
225 schema:familyName Davis
226 schema:givenName Kourtney
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724211141.21
228 rdf:type schema:Person
229 sg:person.0754044324.05 schema:affiliation grid-institutes:grid.47100.32
230 schema:familyName Yood
231 schema:givenName Marianne
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754044324.05
233 rdf:type schema:Person
234 grid-institutes:grid.38142.3c schema:alternateName Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA
235 schema:name Harvard Pilgrim Health Care, Harvard Medical School, Boston, Massachusetts, USA
236 rdf:type schema:Organization
237 grid-institutes:grid.418019.5 schema:alternateName GlaxoSmithKline, Research Triangle Park, North Carolina, USA
238 schema:name GlaxoSmithKline, Research Triangle Park, North Carolina, USA
239 rdf:type schema:Organization
240 grid-institutes:grid.419338.4 schema:alternateName Lovelace Clinic Foundation, Albuquerque, New Mexico, USA
241 schema:name Lovelace Clinic Foundation, Albuquerque, New Mexico, USA
242 rdf:type schema:Organization
243 grid-institutes:grid.47100.32 schema:alternateName Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA
244 schema:name Department of Epidemiology & Public Health, Yale University School of Medicine, Hamden, Connecticut, USA
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...